Genetic Technologies Ltd (NASDAQ:GENE)

1.55
Delayed Data
As of Feb 16
 -0.04 / -2.52%
Today’s Change
0.70
Today|||52-Week Range
2.05
+33.62%
Year-to-Date
Institutional investors purchased a net $398.4 thousand shares of GENE during the quarter ended June 2017, and now own 0.00% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

12/31/2017ALPINE GLOBAL MANAGEMENT LLC  Bought 70.7 Thousand shares of Genetic Technologies Ltd
12/31/2017G1 EXECUTION SERVICES LLC  Bought 21.2 Thousand shares of Genetic Technologies Ltd
12/31/2017PARALLAX VOLATILITY ADVISERS LP  Bought 5.3 Thousand shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
KCG Americas LLC0.00%85,9600+85,960--
KMS Financial Services, Inc.0.00%2,7500+2,750--
Alpine Global Management LLC0.00%70,6570+70,657--
Acrospire Investment Management L...0.00%00-7,216-100.00%
G1 Execution Services LLC0.00%21,2310+21,231--
Morgan Stanley Smith Barney LLC (...0.00%1,5200+20+1.33%
Citigroup Global Markets, Inc. (I...0.00%3000+300--
Cutler Group LP0.00%4,800000.00%
Financial Architects, Inc.0.00%350000.00%
Simplex Trading LLC0.00%5000+500--

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change